These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Park E; Zhu F; Liu B; Xia X; Shen J; Bustos T; Fischer SM; Hu Y Cancer Res; 2007 Oct; 67(19):9158-68. PubMed ID: 17909021 [TBL] [Abstract][Full Text] [Related]
45. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis. Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498 [TBL] [Abstract][Full Text] [Related]
46. Retinol and beta-carotene concentrations in skin, papillomas and carcinomas, liver, and serum of mice fed retinoic acid or beta-carotene to suppress skin tumor formation. Jones CS; Sly L; Chen LC; Ben T; Brugh-Collins M; Lichti U; De Luca LM Nutr Cancer; 1994; 21(1):83-93. PubMed ID: 7910392 [TBL] [Abstract][Full Text] [Related]
47. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells. Agadir A; Shealy YF; Hill DL; Zhang X Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011 [TBL] [Abstract][Full Text] [Related]
48. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis. Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588 [TBL] [Abstract][Full Text] [Related]
49. Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors. Wang DL; Marko M; Dahl AR; Engelke KS; Placke ME; Imondi AR; Mulshine JL; De Luca LM Clin Cancer Res; 2000 Sep; 6(9):3636-45. PubMed ID: 10999756 [TBL] [Abstract][Full Text] [Related]
50. An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Roop DR; Lowy DR; Tambourin PE; Strickland J; Harper JR; Balaschak M; Spangler EF; Yuspa SH Nature; 1986 Oct 30-Nov 5; 323(6091):822-4. PubMed ID: 2430189 [TBL] [Abstract][Full Text] [Related]
51. Development of an in vitro analogue of initiated mouse epidermis to study tumor promoters and antipromoters. Hennings H; Robinson VA; Michael DM; Pettit GR; Jung R; Yuspa SH Cancer Res; 1990 Aug; 50(15):4794-800. PubMed ID: 2114947 [TBL] [Abstract][Full Text] [Related]
52. Similar and synergistic inhibition of gap-junctional communication by ras transformation and tumor promoter treatment of mouse primary keratinocytes. Dotto GP; el-Fouly MH; Nelson C; Trosko JE Oncogene; 1989 May; 4(5):637-41. PubMed ID: 2657578 [TBL] [Abstract][Full Text] [Related]
53. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts. Fernandes ER; Ashendel CL Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672 [TBL] [Abstract][Full Text] [Related]
54. Keratinocyte differentiation induced by calcium, phorbol ester or interferon-gamma elicits distinct changes in the retinoid signalling pathways. Karlsson T; Vahlquist A; Törmä H J Dermatol Sci; 2010 Mar; 57(3):207-13. PubMed ID: 20122816 [TBL] [Abstract][Full Text] [Related]
55. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Boukamp P; Stanbridge EJ; Foo DY; Cerutti PA; Fusenig NE Cancer Res; 1990 May; 50(9):2840-7. PubMed ID: 2183932 [TBL] [Abstract][Full Text] [Related]
56. Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. Tennenbaum T; Yuspa SH; Grover A; Castronovo V; Sobel ME; Yamada Y; De Luca LM Cancer Res; 1992 May; 52(10):2966-76. PubMed ID: 1533815 [TBL] [Abstract][Full Text] [Related]
57. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products. Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577 [TBL] [Abstract][Full Text] [Related]
58. Biological and molecular aspects of radiation carcinogenesis in mouse skin. Bowden GT; Jaffe D; Andrews K Radiat Res; 1990 Mar; 121(3):235-41. PubMed ID: 2315441 [TBL] [Abstract][Full Text] [Related]
59. Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes. Caulín C; Bauluz C; Gandarillas A; Cano A; Quintanilla M Exp Cell Res; 1993 Jan; 204(1):11-21. PubMed ID: 7677983 [TBL] [Abstract][Full Text] [Related]
60. Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss. Boukamp P; Peter W; Pascheberg U; Altmeier S; Fasching C; Stanbridge EJ; Fusenig NE Oncogene; 1995 Sep; 11(5):961-9. PubMed ID: 7675455 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]